Vyepti 100 mg/mL
eptinezumab-jjmr · INJECTION · Lundbeck Pharmaceuticals LLC
No Recall History
Plain English
Vyepti is a injection containing eptinezumab-jjmr at 100 mg/mL, taken intravenous. Manufactured by Lundbeck Pharmaceuticals LLC.
Key Facts
- Brand Name
- Vyepti
- Generic Name
- eptinezumab-jjmr
- NDC Code (Product)
67386-130- Manufacturer
- Lundbeck Pharmaceuticals LLC
- Strength
- 100 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761119
- Drug Class
- Calcitonin Gene-related Peptide Antagonist [EPC]
- Marketing Start
- 02/21/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Vyepti used for?
Vyepti contains eptinezumab-jjmr. It is a injection taken intravenous. Consult your doctor for specific uses.
Is Vyepti a controlled substance?
Vyepti is not classified as a controlled substance by the DEA.
What is the generic name for Vyepti?
The generic name for Vyepti is eptinezumab-jjmr. There are no other listed brand versions of eptinezumab-jjmr.
What is the NDC code for Vyepti 100 mg/mL?
The NDC (National Drug Code) for Vyepti 100 mg/mL is 67386-130, listed by Lundbeck Pharmaceuticals LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)